ArticleFrontiers in public health2026
Trends and inequities in fall- and musculoskeletal disorder-related mortality among U.S. adults aged 65 years and older, 1999-2023.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Musculoskeletal disorders (MSDs) and falls increasingly threaten U.S. older adults. Contemporary trend analyses are essential for targeted prevention. Objective: To assess national and subgroup trends in aggregate mortality attributable to MSDs or falls among U.S. adults aged ≥65 years (1999-2023). Methods: Analyzing CDC WONDER data, deaths with an underlying cause of MSDs or falls were aggregated. We calculated age-adjusted mortality rates (AAMRs) per 100,000 and estimated average annual percent changes (AAPCs) using joinpoint regression, stratified by year, sex, age group, race/ethnicity, state, Census region, and urban-rural classification. Results: From 1999 to 2023, the composite AAMR rose from 51.73 to 98.30 (AAPC = 2.87%). Disaggregated analysis revealed a historic divergence followed by a recent synergistic surge: post-2017, both MSD- and fall-specific mortalities accelerated concurrently (APCs 4.51% and 3.19%). In 2023, the AAMR and AAPC were 111.65 and 2.94% for men, and 88.13 and 2.56% for women, respectively. Non-Hispanic White adults recorded the highest AAMR (110.94). Geographically, the South (AAPC = 3.23%) and non-metropolitan counties (2020 AAMR: 92.17 vs. 85.82) faced the heaviest burdens. State-level AAPCs peaked in Oklahoma (5.70%) and Vermont (5.30%). Conclusions: The macroscopic mortality burden of musculoskeletal decline and falls is worsening. The recent concurrent acceleration in both domains indicates a systemic breakdown in geriatric mobility preservation, highlighting an urgent need for integrated public health interventions targeting high-risk demographics and regions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.